Skip to main content
Skip to main content
LFMD logo

LifeMD, Inc. (LFMD)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

LifeMD, Inc. (LFMD) trades at $3.73 with AI Score 46/100 (Weak). LifeMD, Inc. is a direct-to-patient telehealth company providing virtual medical treatment and prescription medications. Market cap: 180M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
LifeMD, Inc. is a direct-to-patient telehealth company providing virtual medical treatment and prescription medications. They operate across various indications, including men's sexual health, dermatology, and primary care.
46/100 AI Score Target $10.00 (+167.7%) MCap 180M Vol 378K

LifeMD, Inc. (LFMD) Healthcare & Pipeline Overview

CEOJustin Schreiber
Employees304
HeadquartersNew York City, NY, US
IPO Year2008

LifeMD is revolutionizing healthcare access through its direct-to-patient telehealth platform, offering virtual medical treatment and prescription medications across diverse specialties, including men's health, dermatology, and primary care, positioning it for significant growth in the expanding telehealth market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

LifeMD presents a notable research candidate within the rapidly expanding telehealth market. The company's diverse portfolio of virtual care platforms, including ShapiroMD, RexMD, and LifeMD Primary Care, addresses a wide range of patient needs, driving revenue growth. With a gross margin of 87.0%, LifeMD demonstrates strong pricing power and efficient operations. Key growth catalysts include the increasing adoption of telehealth services and the expansion of LifeMD's product offerings. While the company currently operates at a loss with a profit margin of -1.8% and a P/E of -31.49, strategic investments in marketing and technology are expected to drive profitability in the long term. The company's beta of 1.89 indicates higher volatility than the market.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.15B reflects the company's current valuation in the competitive telehealth market.
  • Gross Margin of 87.0% demonstrates strong pricing power and efficient cost management.
  • Operates a diverse portfolio of telehealth platforms, including ShapiroMD, RexMD, and LifeMD Primary Care, catering to various patient needs.
  • Beta of 1.89 indicates higher volatility compared to the broader market.
  • Profit Margin of -1.8% reflects ongoing investments in growth initiatives and marketing.

Competitors & Peers

Strengths

  • Diverse portfolio of telehealth platforms.
  • Strong brand recognition in key markets.
  • Direct-to-patient business model.
  • High gross margin.

Weaknesses

  • Currently operating at a loss.
  • High marketing and customer acquisition costs.
  • Dependence on regulatory approvals.
  • Intense competition in the telehealth market.

Catalysts

  • Expansion of LifeMD Primary Care services to new states.
  • Launch of new telehealth services targeting specific medical conditions.
  • Strategic partnerships with healthcare providers and insurance companies.
  • Increased marketing and brand awareness campaigns.

Risks

  • Changes in telehealth regulations that could restrict the company's operations.
  • Intense competition from other telehealth providers and established healthcare companies.
  • Cybersecurity risks and data breaches that could compromise patient information.
  • Economic downturn affecting consumer spending on elective healthcare services.

Growth Opportunities

  • Expansion of LifeMD Primary Care: LifeMD's virtual primary care platform represents a significant growth opportunity. By offering personalized subscription-based care, urgent care, and chronic care management, LifeMD can capture a larger share of the primary care market. The market for virtual primary care is projected to reach billions of dollars in the coming years, driven by increasing demand for convenient and accessible healthcare. LifeMD's mobile-first platform and integrated services provide a competitive advantage in this rapidly growing market.
  • Strategic Partnerships and Acquisitions: LifeMD can accelerate its growth through strategic partnerships and acquisitions. By partnering with established healthcare providers and acquiring complementary telehealth platforms, LifeMD can expand its reach and service offerings. This strategy allows LifeMD to quickly enter new markets and gain access to new technologies and customer bases. Successful partnerships and acquisitions can significantly enhance LifeMD's competitive position and drive long-term growth.
  • Increased Marketing and Brand Awareness: Investing in marketing and brand awareness is crucial for LifeMD to attract new customers and build brand loyalty. By leveraging digital marketing channels, social media, and targeted advertising campaigns, LifeMD can effectively reach its target audience and increase brand recognition. A strong brand presence will help LifeMD differentiate itself from competitors and drive customer acquisition. The company should focus on highlighting the convenience, affordability, and quality of its telehealth services.
  • Geographic Expansion: LifeMD has the opportunity to expand its services to new geographic markets. By targeting regions with high demand for telehealth services and favorable regulatory environments, LifeMD can increase its customer base and revenue streams. Geographic expansion requires careful planning and execution, including adapting its services to meet the specific needs of each market. Successful geographic expansion can significantly contribute to LifeMD's long-term growth and profitability.
  • Development of New Telehealth Services: LifeMD can drive growth by developing and launching new telehealth services that address unmet patient needs. By leveraging its technology platform and healthcare expertise, LifeMD can create innovative solutions for various medical conditions and patient populations. This includes expanding into areas such as mental health, chronic disease management, and specialized medical consultations. Continuous innovation and service development are essential for LifeMD to maintain its competitive edge and attract new customers.

Opportunities

  • Expansion of telehealth services to new markets.
  • Strategic partnerships and acquisitions.
  • Increased marketing and brand awareness.
  • Development of new telehealth services.

Threats

  • Changing regulatory landscape.
  • Increased competition from established healthcare providers.
  • Cybersecurity risks and data breaches.
  • Economic downturn affecting consumer spending.

Competitive Advantages

  • Proprietary telehealth platform with integrated services.
  • Strong brand recognition in the men's health and dermatology markets.
  • Direct-to-patient business model that eliminates intermediaries.
  • Scalable technology infrastructure that can support future growth.

About LFMD

LifeMD, Inc., founded in 1994 and formerly known as Conversion Labs, Inc., transitioned to its current name in February 2021, marking a strategic shift towards direct-to-patient telehealth services. Headquartered in New York City, LifeMD connects consumers with healthcare professionals, providing care across various indications, including concierge care, men's sexual health, dermatology, and primary care. The company's core offerings include ShapiroMD, a telehealth platform focused on hair loss solutions; RexMD, catering to men's health needs; LifeMD Primary Care, a virtual primary care platform; Cleared, specializing in allergy, asthma, and immunology treatments; and Nava MD, a female-oriented tele-dermatology brand. Additionally, LifeMD offers PDFSimpli, an online software-as-a-service platform for PDF document management. LifeMD distributes its products directly to consumers through e-commerce platforms and via third-party partnerships, expanding its reach and accessibility in the competitive telehealth landscape. With a focus on virtual consultations, prescription medications, and innovative healthcare solutions, LifeMD is positioned to capitalize on the growing demand for convenient and accessible healthcare services.

What They Do

  • Connect consumers with healthcare professionals through a direct-to-patient telehealth platform.
  • Provide virtual medical treatment for various indications, including men's sexual health, dermatology, and primary care.
  • Offer prescription medications and over-the-counter products through its telehealth platforms.
  • Provide personalized subscription-based virtual primary care.
  • Offer a mobile-first platform that incorporates virtual consultations, treatment, prescription medications, diagnostics, and imaging.
  • Provide personalized treatments for allergy, asthma, and immunology.
  • Offer an online software-as-a-service platform for PDF document management.

Business Model

  • Generate revenue through virtual consultations and treatment services.
  • Sell prescription medications and over-the-counter products directly to consumers.
  • Offer subscription-based virtual primary care services.
  • Generate revenue from its PDFSimpli software-as-a-service platform.

Industry Context

LifeMD operates within the rapidly evolving telehealth industry, which is experiencing significant growth due to increasing demand for convenient and accessible healthcare solutions. The market is characterized by intense competition, with companies like CERS, CVRX, HITI, MASS, and OMI vying for market share. LifeMD differentiates itself through its diverse portfolio of specialized telehealth platforms and its focus on direct-to-patient care. The telehealth market is projected to continue its expansion, driven by technological advancements, favorable regulatory changes, and increasing consumer adoption of virtual healthcare services.

Key Customers

  • Individuals seeking virtual medical treatment for various health conditions.
  • Men seeking treatment for sexual health issues.
  • Individuals seeking dermatological care and skincare products.
  • Patients seeking primary care services through a virtual platform.
AI Confidence: 71% Updated: Feb 8, 2026

Financials

Chart & Info

LifeMD, Inc. (LFMD) stock price: $3.73 (-0.20, -5.20%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LFMD.

Price Targets

Consensus target: $10.00

MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates LFMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About LifeMD, Inc. (LFMD) — Healthcare

What does LifeMD, Inc. do?

LifeMD, Inc. operates as a direct-to-patient telehealth company, connecting consumers with healthcare professionals for virtual medical treatment and prescription medications. The company offers a range of specialized telehealth platforms, including ShapiroMD for hair loss, RexMD for men's health, LifeMD Primary Care for virtual primary care, Cleared for allergy and asthma, and Nava MD for tele-dermatology. Additionally, LifeMD provides PDFSimpli, an online software-as-a-service platform for PDF document management. By offering convenient and accessible healthcare solutions, LifeMD aims to improve patient outcomes and disrupt the traditional healthcare model.

Is LFMD stock worth researching?

LFMD stock presents a mixed investment profile. The company's high gross margin of 87.0% and diverse portfolio of telehealth platforms are positive indicators. However, the company's current profitability is a concern, with a profit margin of -1.8% and a P/E of -31.49. Investors may want to evaluate the company's growth potential in the expanding telehealth market, as well as the risks associated with competition and regulatory changes. A balanced approach is recommended, considering both the potential upside and the inherent risks.

What are the main risks for LFMD?

LifeMD faces several key risks, including the potential for changes in telehealth regulations that could restrict its operations. The company also faces intense competition from other telehealth providers and established healthcare companies. Cybersecurity risks and data breaches pose a significant threat, as they could compromise patient information and damage the company's reputation. Additionally, an economic downturn could affect consumer spending on elective healthcare services, impacting LifeMD's revenue and profitability. Careful monitoring of these risks is essential for investors.

What are the key factors to evaluate for LFMD?

LifeMD, Inc. (LFMD) currently holds an AI score of 46/100, indicating low score. Analysts target $10.00 (+168% from $3.73). Key strength: Diverse portfolio of telehealth platforms. Primary risk to monitor: Changes in telehealth regulations that could restrict the company's operations. This is not financial advice.

How frequently does LFMD data refresh on this page?

LFMD prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven LFMD's recent stock price performance?

Recent price movement in LifeMD, Inc. (LFMD) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $10.00 implies 168% upside from here. Notable catalyst: Diverse portfolio of telehealth platforms. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider LFMD overvalued or undervalued right now?

Determining whether LifeMD, Inc. (LFMD) is overvalued or undervalued requires examining multiple metrics. Analysts target $10.00 (+168% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying LFMD?

Before investing in LifeMD, Inc. (LFMD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Investment decisions should be made based on individual risk tolerance and financial circumstances.
Data Sources

Popular Stocks